Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Restoring Physical Resilience: Consistent Functional and Sarcopenia Gains Across Two Vivifrail Cohorts

Early results, not yet checked by other scientists · medRxiv · Oct 16, 2026

What this means

To evaluate change in physical function and probable sarcopenia following a 36-week community multicomponent exercise programme (Vivifrail model) across two consecutive cycles, and to assess the consistency of this change between cohorts. Study design: Quasi-experimental, single-arm, repeated-measures service evaluation.

A plain-English summary is on its way. Until then, this is the start of the authors' own summary.

Tested inNot stated
Who it was tested in
Not stated
Kind of research
Early results, not yet checked by other scientists

The science

Original title
Restoring Physical Resilience: Consistent Functional and Sarcopenia Gains Across Two Vivifrail Cohorts
Authors
Fernandez-Ortega, J., Loza-Herbella, J., Rangel-Garcia, J. A. et al.
Journal
medRxiv (preprint, not yet peer reviewed)
Published
Oct 16, 2026
Study type
Preprint

Abstract

Objectives: To evaluate change in physical function and probable sarcopenia following a 36-week community multicomponent exercise programme (Vivifrail model) across two consecutive cycles, and to assess the consistency of this change between cohorts. Study design: Quasi-experimental, single-arm, repeated-measures service evaluation. Ninety-two older adults (2025-2026 cohort; mean age 75.9 years, 88.0% women) completed baseline and post-intervention assessments; an independent 2024-2025 cohort (n = 86) was analysed jointly for replication (n = 178). Main outcome measures: Short Physical Performance Battery (SPPB) score (primary); Timed Up and Go (TUG), handgrip strength, 6-metre walk time and Mini-Mental State Examination (MMSE) (secondary); probable sarcopenia (EWGSOP2), SPPB-based frailty category, and a fall-risk indicator computed identically in both cohorts. Results: SPPB improved by a mean of 1.33 points (Cohen's d = 0.96; p < .001), with concordant improvement in all four secondary outcomes (all q < .005). 72.8% reached the substantial minimal clinically important difference. Probable sarcopenia fell from 17.4% to 5.4% (p = .006), and frailty category shifted toward higher functional levels (p < .001). Effect sizes were consistent between cohorts for SPPB, handgrip and 6-metre walk; the Time x Cohort interaction was significant for TUG only. In the pooled sample, elevated fall risk fell from 19.7% to 11.2% (p = .002). Conclusions: A 36-week multicomponent exercise programme was associated with clinically meaningful, reproducible improvement in physical function and a reduction in probable sarcopenia across two independent cohorts. The single-arm design precludes causal inference.

Read it on medRxiv ↗

Fernandez-Ortega, J., Loza-Herbella, J., Rangel-Garcia, J. A. et al. Restoring Physical Resilience: Consistent Functional and Sarcopenia Gains Across Two Vivifrail Cohorts. medRxiv. 2026. doi:10.64898/2026.10.14.26365508. https://doi.org/10.64898/2026.10.14.26365508

Report a problem